Michael Vaughn
Family Medicine · Birmingham, ALNPI 1730249525
Payments from drug & device makers
Across 221 payments — averaging $44,713 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$4.5M
- Ortho-clinical Diagnostics, Inc.$2.1M
- Abbott$1.3M
- Quidel Corporation$1M
- Romark Laboratories, LC$417K
- Sekisui Diagnostics LLC$181K
- plus $359K from 23 others
Across 13 payments — averaging $3742.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$43K
- BD$6K
What the payments were for
- Food & beverage$738100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 54 | $4,520,317 |
| Ortho-clinical Diagnostics, Inc. | 19 | $2,114,276 |
| Abbott | 19 | $1,257,575 |
| Quidel Corporation | 8 | $1,032,777 |
| Romark Laboratories, LC | 2 | $416,590 |
| Sekisui Diagnostics LLC | 3 | $180,775 |
| Pfizer | 21 | $95,670 |
| Orasure Technologies Inc. | 3 | $87,425 |
| Genentech, Inc. | 16 | $60,774 |
| BD | 1 | $48,490 |
| AbbVie | 33 | $42,069 |
| Cue Health Inc. | 1 | $16,174 |
| Kowa Research Institute, Inc. | 5 | $7,946 |
| Lilly USA, LLC | 8 | $144 |
| Novo Nordisk | 5 | $83 |
| GSK | 3 | $48 |
| Irhythm Technologies, Inc. | 2 | $41 |
| Novo Nordisk AS | 2 | $36 |
| Dexcom, Inc. | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| AstraZeneca | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$9,881,463 in reported general payments places this provider in the 95th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Birmingham
- Song YuBirmingham$1.7M
- Nova LawBirmingham$649K
- Lashelle BarmoreBirmingham$486K
- Scott WeisbergBirmingham$38K
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.